BARDA’s Division of Research, Innovation, and Ventures (DRIVe) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, are partnering with three non-government organizations to advance the development of microphysiological systems (MPS), also known as tissue chips technology, as part of the BARDA-NCATS ImmuneChip+ Program.
MPS can replicate components of vital human tissues and immune system functions and monitor their interactions. MPS are 3D biophysical platforms comprised of cellular constructs that mimic the structure and function of human tissues and organs, including the lungs, liver, and heart.
{iframe}https://www.medicalcountermeasures.gov/newsroom/2021/immunechip/{/iframe}